|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 332.75 CHF | +0.35% |
|
-0.95% | +1.58% |
| 07-15 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| 07-15 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
EPS & Dividend: Roche Holding AG
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 9.3 | 9.5 | 9.6 | 9.7 | 9.8 | 10.01 | 10.25 | 10.53 |
| Rate of return | 2.45% | 3.27% | 3.93% | 3.8% | 2.99% | 3.02% | 3.09% | 3.17% |
| EPS 2 | 16.2 | 15.37 | 14.31 | 10.31 | 16.04 | 18.72 | 20.11 | 21.91 |
| Distribution rate | 57.4% | 61.8% | 67.1% | 94.1% | 61.1% | 53.5% | 51% | 48% |
| Reference price 2 | 379.10 | 290.50 | 244.50 | 255.50 | 328.20 | 331.60 | 331.60 | 331.60 |
| Nbr of stocks (in thousands) | 800,952 | 800,579 | 798,652 | 796,789 | 796,317 | 795,618 | - | - |
| Announcement Date | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
Past dividends: Roche Holding AG
| 12/03/2026 | Ex-dividend date - 9.8 CHF | 04:00 |
Upcoming Events: Roche Holding AG
| 23/07/2026 | Earnings presentation | 13:00 | |
| 23/07/2026 | Earnings release | Q2 2026 | 06:00 |
| 28/09/2026 | Information meeting | 09:00 | |
| 22/10/2026 | Earnings release | Q3 2026 | 08:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 3.02% | 3.09% | 17.71x | 6.56x | 4.39x | |
| 0.58% | 0.64% | 34.75x | 20.82x | 12.42x | |
| 2.15% | 2.25% | 26.86x | 6.72x | 6.13x | |
| 2.7% | 2.84% | 33.14x | 12662.52x | 7.52x | |
| 2.89% | 2.98% | 21.31x | 6.14x | 5.47x | |
| 1.96% | 2.07% | 21.26x | 4.98x | 4.48x | |
| 2.71% | 2.87% | 24.37x | 18.75x | 6.42x | |
| 2.38% | 2.47% | -49.1x | 8.6x | 5.86x | |
| 6.86% | 6.94% | 12.77x | 1.63x | 3.12x | |
| -.--% | -.--% | 27.8x | 5.57x | 8.4x | |
| Average | 2.53% | 2.61% | 17.09x | 1,274.23x | 6.42x | |
| Weighted average by Cap. | 2.04% | 2.13% | 24.02x | 1,591.01x | 7.76x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition